Industry Calls the Climate Shots in the Biden Administration
And you believed Biden on climate change?
Read more...Category Archives: Politics
America’s Afghan War Is Over, So What About Iraq – and Iran?
America is finally out of one unwinnable war. How does this bode for the US extracting itself from other Middle Eastern quagmires?
Read more...Michael Hudson Discusses Financialization, Rentierism, and Other Favorite Topics with Jessi Ora of Swedish Positiva Pengar Group
Michael Hudson gives another wide-ranging, tour de force interview. Enjoy!
Read more...Steve Wozniak Endorses the Right to Repair
Last week, President Joe Biden and Apple co-founder Steve Wozniak endorsed the right to repair.
Read more...Purdue Bankruptcy Plan Moves Closer to Approval: Sacklers Would Make Out Well and Preserve Much of the Family Fortune, Despite the Opioids Crisis
Last week fifteen states dropped opposition to Purdue Pharma’s bankruptcy exit plan, making it likely the plan will be approved when it comes before a federal bankruptcy judge in August.
Read more...Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
The largest drug companies are far more interested in enriching themselves and investors than in developing new drugs, according to a House committee report released Thursday
Read more...New York City Subway Flooding Demonstrates Transit System Vulnerability to Climate Change
More frequent and severe New York City subway floods demonstrate how climate change is crippling critical infrastructure.
Read more...Trump Can’t Beat Facebook, Twitter and YouTube in Court – but the Fight Might Be Worth More Than a Win
Trump is back for another misguided, erm, quixotic fight. Could he still score points?
Read more...Moving the Covid Vaccine Goalposts
The Covid propagation and vaccine news is not pointing to happy outcomes
Read more...The Future of Alzheimer’s Pharmaceutical Aducanumab – as a Medicine and as a Financial Product – What Happens Now?
The more you look at aducanumab, both the dubious FDA approval and the thin odds that it will perform medically, the less there is to like.
Read more...War on Science Persists Within Biden EPA as Staffers Allege Chemical Reports Altered
Whistleblowers charge that Trump-style doctoring of scientific reports is continuing under Biden.
Read more...The Real Reason OPEC Talks Broke Down
OPEC is squabbling again. Will the factions settle their hash?
Read more...A Quick Comment on China Stomping on Chinese Stock Listings in the US
Another big and costly dustup over Chinese listings in the US. But now Chinese officials signal they want broad-scale change.
Read more...Aducanumab Approval, Part 2: Dirty Drug Dealings
Yves here. We’re doing a bit of catchup by featuring some significant stories that were still crowded out a bit due to the competing news plus the Fourth of July tuneout. One is on the super dodgy approval of the big ticket, very dubious effectiveness Alzheimer’s drug Aducanumab. And “big ticket” is no understatement; the […]
Read more...An Independence Day Reflection: How the Rich Plan to Rule a Burning World
How do the rich intend to carry on as general conditions deteriorate?
Read more...